FLG and Alzheimer disease: Filaggrin (FLG) reduction, a hallmark of AD skin lesions associated with skin barrier dysfunction, was effectively inhibited by HPH in TNF-α/IFN-γ- stimulated HaCaT cells (Fig. 2D).